Role of the hydrophobic and charged residues in the 218-226 region of apoA-I in the biogenesis of HDL

Journal of Lipid Research

Volumn 54, Issue 12, 2013, Pages 3281-3292

  Fotakis, Panagiotis ^a,b   Kateifides, Andreas K ^a,b   Gkolfinopoulou, Christina ^c   Georgiadou, Dimitra ^c   Beck, Melissa ^a,b   Gründler, Katharina ^a   Chroni, Angeliki ^c   Stratikos, Efstratios ^c   Kardassis, Dimitris ^a   Zannis, Vassilis I ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CRETE   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Apolipoprotein A I mutations; Dyslipidemia; LCAT; Pre and HDL particles

Indexed keywords

ABC TRANSPORTER A1; ADENOVIRUS VECTOR; ALPHA HIGH DENSITY LIPOPROTEIN; ALPHA4 HIGH DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PRE BETA HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE TRANSFER; HYDROPHOBICITY; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

APOLIPOPROTEIN A-I MUTATIONS; DYSLIPIDEMIA; LCAT; PRE-Β AND Α-HDL PARTICLES;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEIN A-I; CELL LINE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOPROTEINS, HDL; MICE; MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN UNFOLDING; TEMPERATURE; TRANSGENES;

EID: 84887954240     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M038356     Document Type: Article

References (39)

1. Chroni, A., T. Liu, I. Gorshkova, H. Y. Kan, Y. Uehara, A. Von Eckardstein, and V. I. Zannis. 2003. The central helices of apoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type apoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J. Biol. Chem. 278:6719-6730. (Pubitemid 36800659)
2. Liu, T., M. Krieger, H. Y. Kan, and V. I. Zannis. 2002. The effects of mutations in helices 4 and 6 of apoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for efficient lipid transport. J. Biol. Chem. 277:21576-21584. (Pubitemid 34952304)
3. Hassan, H. H., M. Denis, D. Y. Lee, I. Iatan, D. Nyholt, I. Ruel, L. Krimbou, and J. Genest. 2007. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis. J. Lipid Res. 48:2428-2442. (Pubitemid 350058754)
4. Zannis, V. I., A. Chroni, K. E. Kypreos, H. Y. Kan, T. B. Cesar, E. E. Zanni, and D. Kardassis. 2004. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. Curr. Opin. Lipidol. 15:151-166. (Pubitemid 38455477)
5. Singaraja, R. R., M. Van Eck, N. Bissada, F. Zimetti, H. L. Collins, R. B. Hildebrand, A. Hayden, L. R. Brunham, M. H. Kang, J. C. Fruchart, et al. 2006. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo. Circulation. 114:1301-1309. (Pubitemid 44402056)
6. Chung, S., J. K. Sawyer, A. K. Gebre, N. Maeda, and J. S. Parks. 2011. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo. Circulation. 124:1663-1672.
7. Kiss, R. S., N. Kavaslar, K. Okuhira, M. W. Freeman, S. Walter, R. W. Milne, R. McPherson, and Y. L. Marcel. 2007. Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects. Arterioscler. Thromb. Vasc. Biol. 27:1139-1145. (Pubitemid 46646651)
8. Cohen, J. C., R. S. Kiss, A. Pertsemlidis, Y. L. Marcel, R. McPherson, and H. H. Hobbs. 2004. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 305:869-872. (Pubitemid 39038422)
9. Frikke-Schmidt, R., B. G. Nordestgaard, G. B. Jensen, and A. Tybjaerg-Hansen. 2004. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J. Clin. Invest. 114:1343-1353. (Pubitemid 40385306)
10. Zannis, V. I., E. E. Zanni, A. Papapanagiotou, D. Kardassis, and A. Chroni. 2006. ApoA-I functions and synthesis of HDL: insights from mouse models of human HDL metabolism. In High-Density Lipoproteins. From Basic Biology to Clinical Aspects. Wiley-VCH, Weinheim. 237-265.
11. Koukos, G., A. Chroni, A. Duka, D. Kardassis, and V. I. Zannis. 2007. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Biochem. J. 406:167-174. (Pubitemid 47264747)
12. Koukos, G., A. Chroni, A. Duka, D. Kardassis, and V. I. Zannis. 2007. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg) Pisa and (Leu159Arg) FIN. Biochemistry. 46:10713-10721. (Pubitemid 47417263)
13. Chroni, A., A. Duka, H. Y. Kan, T. Liu, and V. I. Zannis. 2005. Point mutations in apolipoprotein a-I mimic the phenotype observed in patients with classical lecithin: cholesterol acyltransferase defi-ciency. Biochemistry. 44:14353-14366. (Pubitemid 41534670)
14. Chroni, A., H. Y. Kan, K. E. Kypreos, I. N. Gorshkova, A. Shkodrani, and V. I. Zannis. 2004. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice. Biochemistry. 43:10442-10457. (Pubitemid 39079318)
15. Chroni, A., G. Koukos, A. Duka, and V. I. Zannis. 2007. The carboxyterminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo. Biochemistry. 46:5697-5708. (Pubitemid 46764119)
16. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:12291-12296. (Pubitemid 27492521)
17. Borhani, D. W., J. A. Engler, and C. G. Brouillette. 1999. Crystallization of truncated human apolipoprotein A-I in a novel conformation. Acta Crystallogr. D Biol. Crystallogr. 55:1578-1583. (Pubitemid 29449867)
18. Mei, X., and D. Atkinson. 2011. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J. Biol. Chem. 286:38570-38582.
19. Segrest, J. P., L. Li, G. M. Anantharamaiah, S. C. Harvey, K. N. Liadaki, and V. Zannis. 2000. Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr. Opin. Lipidol. 11:105-115. (Pubitemid 30219104)
20. Ohnsorg, P. M., L. Rohrer, D. Perisa, A. Kateifides, A. Chroni, D. Kardassis, V. I. Zannis, and A. Von Eckardstein. 2011. Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells. J. Biol. Chem. 286:7744-7754.
21. Biedzka-Sarek, M., J. Metso, A. Kateifides, T. Meri, T. S. Jokiranta, A. Muszynski, J. Radziejewska-Lebrecht, V. Zannis, M. Skurnik, and M. Jauhiainen. 2011. Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3. J. Biol. Chem. 286:38211-38219.
22. Amar, M. J., R. D. Shamburek, B. Vaisman, C. L. Knapper, B. Foger, R. F. Hoyt, Jr., S. Santamarina-Fojo, H. B. Brewer, Jr., and A. T. Remaley. 2009. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein. Metabolism. 58:568-575.
23. Matz, C. E., and A. Jonas. 1982. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257:4535-4540.
24. Williamson, R., D. Lee, J. Hagaman, and N. Maeda. 1992. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 89:7134-7138.
25. Thorngate, F. E., P. G. Yancey, G. Kellner-Weibel, L. L. Rudel, G. H. Rothblat, and D. L. Williams. 2003. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression. J. Lipid Res. 44:2331-2338. (Pubitemid 38082491)
26. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
27. Chroni, A., H. Y. Kan, A. Shkodrani, T. Liu, and V. I. Zannis. 2005. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice. Biochemistry. 44:4108-4117. (Pubitemid 40358064)
28. Duka, A., P. Fotakis, D. Georgiadou, A. Kateifides, K. Tzavlaki, L. Von Eckardstein, E. Stratikos, D. Kardassis, and V. I. Zannis. 2013. ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT. J. Lipid Res. 54:107-115.
29. Kateifides, A. K., I. N. Gorshkova, A. Duka, A. Chroni, D. Kardassis, and V. I. Zannis. 2011. Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL. J. Lipid Res. 52:1363-1372.
30. Rothblat, G. H., M. Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips. 1999. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40:781-796. (Pubitemid 29220519)
31. Fielding, C. J., and P. E. Fielding. 2001. Cellular cholesterol efflux. Biochim. Biophys. Acta. 1533:175-189. (Pubitemid 33127270)
32. Wang, N., D. L. Silver, P. Costet, and A. R. Tall. 2000. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275:33053-33058.
33. Remaley, A. T., J. A. Stonik, S. J. Demosky, E. B. Neufeld, A. V. Bocharov, T. G. Vishnyakova, T. L. Eggerman, A. P. Patterson, N. J. Duverger, S. Santamarina-Fojo, et al. 2001. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280:818-823. (Pubitemid 32924503)
34. Timmins, J. M., J. Y. Lee, E. Boudyguina, K. D. Kluckman, L. R. Brunham, A. Mulya, A. K. Gebre, J. M. Coutinho, P. L. Colvin, T. L. Smith, et al. 2005. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115:1333-1342. (Pubitemid 40629053)
35. Kypreos, K. E., and V. I. Zannis. 2007. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochem. J. 403:359-367. (Pubitemid 46596593)
36. Daniil, G., A. A. Phedonos, A. G. Holleboom, M. M. Motazacker, L. Argyri, J. A. Kuivenhoven, and A. Chroni. 2011. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders. Clin. Chim. Acta. 412:1213-1220.
37. Francone, O. L., P. V. Subbaiah, A. Van Tol, L. Royer, and M. Haghpassand. 2003. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry. 42:8569-8578. (Pubitemid 36875424)
38. Asztalos, B. F., M. E. Brousseau, J. R. McNamara, K. V. Horvath, P. S. Roheim, and E. J. Schaefer. 2001. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis. 156:217-225. (Pubitemid 32429615)
39. Arakawa, R., and S. Yokoyama. 2002. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277:22426-22429. (Pubitemid 34967213)